Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma. - Scheithauer, W; Kornek, G V; Raderer, M; Hejna, M; Valencak, J; Miholic, J; Kovats, E; Lang, F; Funovics, J; Bareck, E; Depisch, D (British Journal of Cancer, 1999)